These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28802902)

  • 1. Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection treated cytokine-induced killer cells combined with chemotherapy in the treatment of malignancies.
    Zhang C; Zhang Z; Wang L; Han J; Li F; Shen C; Li H; Huang L; Zhao X; Yue D; Huang J; Yan Y; Zhang Y
    Int Immunopharmacol; 2017 Oct; 51():57-65. PubMed ID: 28802902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa injection enhanced antitumor cytotoxicity of cytokine-induced killer cells derived from cord blood.
    Zhang Z; Wang LP; Zhao XL; Wang F; Huang L; Wang M; Chen XF; Li H; Zhang Y
    Biomed Pharmacother; 2014 Oct; 68(8):1057-63. PubMed ID: 25465152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).
    Gu Y; Lv H; Zhao J; Li Q; Mu G; Li J; Wuyang J; Lou G; Wang R; Zhang Y; Huang X
    Int Immunopharmacol; 2017 Sep; 50():263-269. PubMed ID: 28711032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of cord blood-derived cytokine-induced killer cells in treatment of patients with malignancies.
    Zhang Z; Wang L; Luo Z; Zhao X; Huang J; Li H; Yang S; Zhao X; Zhang L; Li L; Wang F; Huang L; Zhang Y
    Cytotherapy; 2015 Aug; 17(8):1130-8. PubMed ID: 25963952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients.
    Yang L; Ren B; Li H; Yu J; Cao S; Hao X; Ren X
    Cancer Immunol Immunother; 2013 Jan; 62(1):65-73. PubMed ID: 22744010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer.
    Huang J; Kan Q; Lan ; Zhao X; Zhang Z; Yang S; Li H; Wang L; Xu L; Cheng Z; Zhang Y
    Int Immunopharmacol; 2017 May; 46():170-177. PubMed ID: 28292730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy with sequential cytokine-induced killer (CIK) cells in stage IB non-small cell lung cancer.
    Li DP; Li W; Feng J; Chen K; Tao M
    Oncol Res; 2015; 22(2):67-74. PubMed ID: 25706393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients.
    Zhang L; Wang J; Wei F; Wang K; Sun Q; Yang F; Jin H; Zheng Y; Zhao H; Wang L; Yu W; Zhang X; An Y; Yang L; Zhang X; Ren X
    Oncotarget; 2016 Jul; 7(28):43604-43615. PubMed ID: 27283895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancer.
    Wang M; Cao JX; Pan JH; Liu YS; Xu BL; Li D; Zhang XY; Li JL; Liu JL; Wang HB; Wang ZX
    PLoS One; 2014; 9(11):e112662. PubMed ID: 25412106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-induced Killer T Cells Enhance the Cytotoxicity Against Carboplatin-resistant Ovarian Cancer Cells.
    Pan Y; Chiu YH; Chiu SC; Cho DY; Lee LM; Wen YC; Whang-Peng J; Hsiao CH; Shih PH
    Anticancer Res; 2020 Jul; 40(7):3865-3872. PubMed ID: 32620626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous Injections of the Mannose-Sensitive Hemagglutination Pilus Strain of Pseudomonas aeruginosa Stimulate Host Immunity, Reduce Bladder Cancer Size and Improve Tumor Survival in Mice.
    Li T; Yang L; Fu SJ; Xiao EL; Yuan X; Lu JZ; Ma BL; Shi TK; Wang ZP
    Cell Biochem Biophys; 2015 Sep; 73(1):245-52. PubMed ID: 25724441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancer.
    Zhu Y; Zhang H; Li Y; Bai J; Liu L; Liu Y; Qu Y; Qu X
    Cancer Immunol Immunother; 2013 Oct; 62(10):1629-35. PubMed ID: 23974720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
    Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
    Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
    Wu C; Jiang J; Shi L; Xu N
    Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killing effects of Huaier Granule combined with DC-CIK on nude mice transplanted with colon carcinoma cell line.
    Sun WW; Dou JX; Zhang L; Qiao LK; Shen N; Zhao Q; Gao WY
    Oncotarget; 2017 Jul; 8(28):46081-46089. PubMed ID: 28537906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy with autologous cytokine-induced killer cells in patients with advanced epithelial ovarian cancer after first-line treatment.
    Liu J; Li H; Cao S; Zhang X; Yu J; Qi J; An X; Yu W; Ren X; Hao X
    J Immunother; 2014; 37(2):115-22. PubMed ID: 24509174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cycles of DC/CIK immunotherapy decreases frequency of Tregs in patients with resected NSCLC.
    Song H; Liu S; Zhao Z; Sun W; Wei X; Ma X; Zhao P; Gao D
    Int Immunopharmacol; 2017 Nov; 52():197-202. PubMed ID: 28941416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
    Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
    Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
    Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
    World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.